NCT01736956View on ClinicalTrials.gov

Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Aortic StenosisHypoplastic Left Heart Syndrome
Interventions
PROCEDURE

Fetal Aortic Valvuloplasty

Fetuses in the intervention group will undergo in utero balloon aortic valvuloplasty via a transuterine, perventricular approach. Fetuses in the control group will have no invasive intervention while in utero.

Trial Locations (1)

94158

University of California, San Francisco Fetal Treatment Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01736956 - Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome | Biotech Hunter | Biotech Hunter